danah benefit flu season dental weak
updat forecast estim jan
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research apr
estim jan
price data may
rate updat may
currenc amount express
valuat growth profit
methodolog valu compani
uniqu busi impress histor result
compani strategi reli success manag
continu capit alloc acumen integr effort
underli
busi perform conserv use financ suggest
compani remain disciplin strategi risk
recent deal like pall nobel cepheid brought
innov industri leader higher growth opportun
expens return capit taken slide
recent year mostli like long-term outlook
major busi wed like see
evid manag wont overpay growth
follow spin-off primarili
diversifi healthcar compani continu focu nich
market continu appreci direct
segment life scienc diagnost remain attract area
age popul demograph growth
person medicin demand biolog manufactur
custom base recur consum drive cash flow similarli
danah consolid dental industri boost exposur
mostli cash pay healthcar market also enjoy
fragment custom base purchas innov
implant manufactur nobel better posit firm
attract specialti dental market lower-pr competit
remain concern space
see number potenti avenu manag continu
deploy capit boost competit edg diagnost
exampl gain access molecular diagnost
cepheid deal manag may want
enhanc exposur molecular genom test life
scienc side could boost chromatographi
equip handheld scanner chairsid mill clear
align high growth area
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
spin-off diversifi mostli
healthcare-focus instrument suppli manufactur spin
dental environment appli solut segment repres
approxim revenu respect
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
danah benefit flu season dental
dont anticip materi chang fair valu
estim narrow-moat follow compani
first-quart result organ growth quarter
continu mostli match expect currenc
remain consider tailwind ad top
line manag increas year-end adjust ep
outlook plan increas forecast
slightli current ep estim alreadi
manag previou guidanc rang
perform segment continu
track expect except dental
busi integr cepheid -- attain
growth quarter thank larg harsh flu
season -- sustain high growth diagnost
divis post organ growth quarter
exclud temporari flu benefit think cepheid
busi maintain low mid-teen growth meanwhil
manag note competit pressur
matur diagnost oper market specif
hematolog off-set strength emerg market like
china last doesnt seem face neg
consequ center medicar medicaid
organ sale declin basi point
oper margin eros dental busi trail
expect even though anticip near-term
weak divis manag seem confid
recent distribut channel inventori adjust
abat near end year
eventu improv trajectori profit
busi howev surpris see
gener
consum equip area despit stabl
perform compani specialti consum like
challeng
final think billion acquisit
integr dna technolog help expand firm
exposur attract high-growth genom
market time sale deal price seem
fair given growth outlook busi similar
recent acquisit cepheid think
continu focu market segment think
life scienc diagnost busi
underexpos peer roch anticip
capit deploy area even though asset like
becom less abund on-going consolid
valuat growth profit feb
increas fair valu estim
per share rais growth forecast base
recent strong perform near-term currenc
multipl
forecast averag annual growth
next five year thank organ growth
growth acquisit primarili life scienc
diagnost dental segment expect danah
abl maintain low mid-single-digit organ growth
product segment life scienc
model small tuck-in acquisit minor
contribut sale growth acknowledg larger
unpredict deal like drive higher
growth expens capit deploy
forecast oper margin near
eventu rise next five year
integr pall nobel cepheid along
on-going cost save effort lead consider margin
expans life scienc diagnost dental
segment current compani lower margin
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
better-than-expect integr result deal -- particularli
pall nobel cepheid -- result oper margin near
return capit also rise midteen
scenario
persist weak global macroeconom condit
manag inabl spur higher growth
product develop market effort result
rel lacklust total annual growth
organ acquisit next five year
worse-than-expect integr effort addit
weak top-lin perform doesnt allow manag
effici scale oper lead modest margin
expans high-teen return capit also
bare reach bear case scenario
result fair valu estim
maintain narrow-moat rate danah
follow spin-off includ
test measur oper fluke tektronix
root industri technolog segment
kollmorgen thomson jacob vehicl danah
remain diversifi predomin healthcare-focus
busi retain life scienc diagnost dental
water qualiti product
recur consum revenu make
benefit
predomin switch cost intang asset
also like gain modest benefit economi
scale layer adjac busi roll-up
acquisit gain consolid
improv sell distribut
purchas
effici compet
mani
commodit market howev differenti product
innov meet custom need remain
divis expect much margin improv
danah environement appli solut busi
alreadi post oper margin
assumpt result return invest capit gradual
rise back estim danah
cost capit approxim
danah diversif presenc mani stabl
industri reduc compani overal risk view
manag consist strategi creat
meaning integr overpay risk manag
abil integr pall continu turnaround nobel
oper improv cepheid profit
larg bear near-term perform exampl
fair valu estim bull case
assum stronger organ growth help part better
macroeconom condit lead higher spend
equip dental procedur lead annual
growth organ acquisit
next
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
busi compet compani like ge siemen
among other
think danah moat trend stabl dont forese
major disrupt technolog risk competit headwind
compani market risk increas
commodit persist area like gener dental
consum market equip offer
specialti dental product includ integr
nobel implant busi help retain overal
competit edg modest innov keep danah
competit advantag stabl manag like
continu use acquisit fill area
compani lack industri presenc recent
cepheid deal attain access molecular diagnost
market could also choos bolster life scienc
diagnost oper expand product breadth
build greater capabl area ga
liquid chromatographi
critic moat sourc view
 strategi continu focu mostli nich
oligopolist market high barrier entri creat
combin complex
instrument high switch cost extens brand
recognit nearli revenu spin-off
life scienc diagnost segment
includ legaci beckman coulter sciex leica
pall cepheid busi rel high switch
cost larg instal base equip becom
essenti compon custom workflow system
stabl instal base equip support consist
pull consum make bulk
sale divis similarli dental segment
includ implant acquir recent nobel deal
orthodont ormco directli sold specialist
demand newer innov technolog high qualiti
materi addit remain hesit switch brand
due previou train also major player
dental imag equip
although typic market leader
product categori compani remain larg
signific player industri innov
sticki relationship help preserv compani
brand number four player diagnost
exampl compet heavili roch
siemen abbott high volum clinic chemistri
immunoassay market also contend
hematolog compet sysmex anatom
patholog compet primarili roch
agil molecular diagnost asset acquir
cepheid pit compani player like roch
biomerieux second largest
dental player dentspli recent acquisit
nobel make compani one key innov
premium implant market filtrat water
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
post impress track record
deal enabl compani creat
competit busi boost asset
perform focu improv effici
market leadership
 strategi find busi
attract healthcar market led roic declin
year especi pursuit implant
manufactur nobel filtrat purif
odanah shift healthcar market creat less
cyclic busi attract market high
entri
plenti opportun consolid
improv perform variou fragment
diagnost dentistri
outstand leader
market roch siemen repres larger
potenti innov competit
osom market
exampl nobel previous suffer low
price open sourc competit lucr
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
strategi think compani maintain rel healthi
financ thank compani strong oper cash flow
combin fairli conserv use credit equiti
financ transact compani debt balanc
consider increas financ pall acquisit
follow cepheid acquisit
debt remain manag firm produc
healthi cash flow cover debt oblig pay small
dividend anticip net debt/adjust ebitda
time danah ebitda interest coverag ratio
histor remain time compani
dividend yield
think danah aggress strategi creat
risk compani particularli manag
begin consist overpay asset integr
effort larg busi fail make gain materi
danah on-going shift healthcar also expos
firm market requir consist innov
howev manag stabl histori integr
busi sustain growth profit
leverag balanc sheet help keep
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
repres date owner name posit common share held report holder issuer
govern pension fund norway global
share
fund
share
fund
compani high level risk compani
histor perform sharehold align
firm view although recent declin return
capit reason concern favor view
manag histor capit alloc decis
focus asset industri certain
attract characterist combin manag
abil improv oper perform
danah busi system includ lean-manufactur
japanes system continu
improv empow leadership focus
custom need combin enabl
becom major player mani attract market
materi improv mani acquir busi
impair rare compani
support view manag follow disciplin
strategi process
co-found brother mitchel steven rale retain
influenc compani creat
mitchel rale chairman execut committe
steven rale chairman board also
cumul approxim outstand
share thoma joyc join becam
ceo follow mani previou leadership posit
compani recent water qualiti life
scienc diagnost segment joyc also join rale
brother compani board donald ehrlich
lead independ director board sinc
begin matthew mcgrew -- lead
financ firm disgnost dental divis --
replac daniel coma cfo compani
transit retir director elect annual
execut compens mostli tie adjust ep
target also includ free cash flow ratio return
invest capit metric wed prefer return capit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
play larger role determin compens
 heavi firm like think compani
fairli shareholder-friendli
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
organ sale slightli quarter danah
dental segment remain near-term drag think
busi mix shift toward specialti product help
improv segment outlook stabl growth specialti
consum includ high-single-digit growth nobel
implant busi help off-set persist weak
equip commodit dental consum
manag continu point shift distributor
relationship -- especi patterson henri schein --
among competitor
adjust still concern increas
long term
solid life scienc diagnost
perform continu off-set dental pressur jan
danah report strong fourth-quart result view
report growth stem currenc
benefit contribut acquisit along
nearli basi point oper margin expans
last year probabl increas fair valu
estim slightli revisit growth margin
assumpt manag outlook
adjust earn per share remain
recent tax reform currenc tailwind add
leav narrow moat rate place
although dental segment weak like persist
anticip healthi growth margin expans
continu year led life
scienc diagnost segment life scienc segment
report particularli strong growth basi
point oper margin expans fourth quarter
segment probabl wit approxim
benefit delay relat hurrican issu
surprisingli posit particularli beckman coulter
pall busi
diagnost segment also continu post healthi
growth margin expans recent cepheid
acquisit exceed expect thank nearli
growth led grow instal base new
instrument new test like temporari benefit
virul flu season continu think
cepheid acquisit benefit molecular
diagnost remain one higher-growth area
market combin firm uniqu instrument
expand test menu
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
